Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$412M |
| 2 |
Advanced Micro Devices
AMD
|
+$294M |
| 3 |
Apple
AAPL
|
+$244M |
| 4 |
Qualcomm
QCOM
|
+$207M |
| 5 |
Pinduoduo
PDD
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$510M |
| 2 |
Uber
UBER
|
+$419M |
| 3 |
Chevron
CVX
|
+$286M |
| 4 |
Meta Platforms (Facebook)
META
|
+$255M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.64% |
| 2 | Healthcare | 18.28% |
| 3 | Consumer Discretionary | 13.73% |
| 4 | Industrials | 8.65% |
| 5 | Financials | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AUGX
3301
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $46.8K | ﹤0.01% |
53,200
-27,000
| -34% | -$55.7K |
|
3302
Zevia
ZVIA
$104M
| $46.8K | ﹤0.01% |
69,300
+39,000
| +129% | +$36.1K |
|
|
AKTX
3303
Akari Therapeutics
AKTX
$12.6M
| $46.1K | ﹤0.01% |
427
+58
| +16% | +$4.28K |
|
|
MKFG
3304
DELISTED
Markforged Holding Corporation
MKFG
| $46K | ﹤0.01% |
11,230
-19,585
| -64% | -$107K |
|
3305
SurgePays
SURG
$6.2M
| $45.3K | ﹤0.01% |
+14,200
| New | +$53.7K |
|
|
YQ
3306
17 Education & Technology Group
YQ
$24.1M
| $43.9K | ﹤0.01% |
20,530
-100
| -0.5% | -$254 |
|
3307
Rapid Micro Biosystems
RPID
$84.8M
| $43.6K | ﹤0.01% |
65,987
+8,600
| +15% | +$7.35K |
|
|
NCNA
3308
NuCana
NCNA
$6.16M
| $42.9K | ﹤0.01% |
84
| – | – |
|
|
NXXT
3309
NextNRG Inc
NXXT
$54.2M
| $42K | ﹤0.01% |
+8,732
| New | +$50.6K |
|
|
ASLN
3310
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
| $41.7K | ﹤0.01% |
17,358
+2,045
| +13% | +$7.24K |
|
|
BYU
3311
DELISTED
BAIYU Holdings, Inc. Common Stock
BYU
| $41.1K | ﹤0.01% |
35,000
-15,100
| -30% | -$18.1K |
|
3312
SHF Holdings
SHFS
$2.17M
| $40.5K | ﹤0.01% |
3,783
-3,787
| -50% | -$54.9K |
|
3313
Modular Medical
MODD
$11.2M
| $40.1K | ﹤0.01% |
+847
| New | +$41.4K |
|
|
KORE
3314
DELISTED
KORE Group Holdings
KORE
| $39.9K | ﹤0.01% |
18,840
+1,260
| +7% | +$4.4K |
|
3315
Indonesia Energy Corp
INDO
$45.1M
| $39.5K | ﹤0.01% |
14,378
-11,322
| -44% | -$39.1K |
|
|
ADIL
3316
Adial Pharmaceuticals
ADIL
$9.43M
| $39.5K | ﹤0.01% |
1,374
-670
| -33% | -$25.3K |
|
|
MOGU
3317
MOGU Inc
MOGU
$15.3M
| $39K | ﹤0.01% |
16,257
-300
| -2% | -$661 |
|
3318
SELLAS Life Sciences
SLS
$2.5B
| $38.6K | ﹤0.01% |
+32,446
| New | +$44.1K |
|
3319
Grove Collaborative
GROV
$44.4M
| $38.4K | ﹤0.01% |
+21,700
| New | +$34.7K |
|
|
DYNT
3320
DELISTED
Dynatronics Corp
DYNT
| $38.3K | ﹤0.01% |
144,418
+9,600
| +7% | +$4.12K |
|
3321
DSS Inc
DSS
$5.15M
| $38.1K | ﹤0.01% |
22,148
+1,000
| +5% | +$1.77K |
|
|
CCM
3322
Concord Medical Services
CCM
$20.8M
| $37.1K | ﹤0.01% |
3,910
-160
| -4% | -$1.07K |
|
3323
AmpliTech
AMPG
$152M
| $35.9K | ﹤0.01% |
34,200
-23,600
| -41% | -$41.9K |
|
|
BRNS
3324
Barinthus Biotherapeutics
BRNS
$23.8M
| $35.1K | ﹤0.01% |
25,100
-2,600
| -9% | -$5.87K |
|
|
FRSX
3325
Foresight Autonomous Holdings
FRSX
$4.02M
| $34.4K | ﹤0.01% |
1,707
+333
| +24% | +$7.76K |
|
Similar funds
Jim Simons's Q2 2024 Portfolio in Review
As of Q2 2024, Jim Simons held 4,123 positions worth $59B, down 7.3% from $63.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $4.49B in Q2 2024, closing 674 positions and reducing 1,503 holdings. Its most notable exit was Bank of America, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Broadcom worth $472M.
- Jim Simons's largest Q2 2024 buy was Broadcom: 2,941,150 shares worth $472M.
- Jim Simons added most to Apple in Q2 2024, an estimated $244M increase.
- Jim Simons's biggest Q2 2024 reduction was Amazon, cutting an estimated $510M.
- Jim Simons fully exited Bank of America in Q2 2024, selling an estimated $142M.
- Jim Simons's ten largest holdings make up 12% of its $59B portfolio in Q2 2024.
- Jim Simons opened 463 new positions and closed 674 in Q2 2024.
- Jim Simons's portfolio value fell 7.3% quarter-over-quarter to $59B.
Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.